Clinical Trial

Bioequivalence Study of Lidocaine and Prilocaine Cream in Healthy Chinese Subjects

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The test formulation (Lidocaine and Prilocaine Cream, Haisco Pharmaceutical Group Co., Ltd.) and the reference formulation (EMLA®, AstraZeneca) were applied to healthy adult subjects under fasting conditions to evaluate the bioequivalence and safety of the two formulations
Trial Details
NCT Number NCT07551713
Lead Sponsor Haisco Pharmaceutical Group Co., Ltd.
Conditions Healthy
Enrollment 40 participants
Start Date 2020-06-11
Primary Completion 2020-07-10 (estimated)
Study Completion 2020-09-28 (estimated)
Updated on ClinicalTrials.gov 2026-04-27